Regional Management insider sale: 10,000 shares via 10b5-1 plan
Rhea-AI Filing Summary
Robert William Beck, President and CEO and a director of Regional Management Corp. (RM), reported sales of common stock on 08/11/2025. The filings show two dispositions executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 09/04/2024.
The report lists sales of 5,656 shares at a weighted average price of $35.32 (per-range $34.54–$35.53) and 4,344 shares at a weighted average price of $35.82 (per-range $35.54–$36.16), totaling 10,000 shares sold. Post-transaction beneficial ownership is reported as 79,673 shares.
Positive
- Sales executed under a Rule 10b5-1 trading plan, indicating the transactions were preplanned (plan adopted 09/04/2024).
- Detailed disclosure provided including weighted-average prices, price ranges, and post-transaction beneficial ownership, with an attorney-in-fact signature on 08/12/2025.
Negative
- Insider sale of 10,000 shares (5,656 and 4,344 shares), which reduces the reporting person's beneficial ownership to 79,673 shares.
- No information in the filing about percentage ownership or context relative to total outstanding shares, limiting assessment of materiality.
Insights
TL;DR: CEO sold 10,000 RM shares under a pre-existing 10b5-1 plan; transactions appear routine and preplanned.
The Form 4 discloses two separate sales on 08/11/2025 by Robert William Beck executed under a Rule 10b5-1 plan adopted on 09/04/2024. The sales total 10,000 shares with reported weighted-average prices of $35.32 and $35.82 and reported price ranges for each tranche. Because the trades were made pursuant to a documented 10b5-1 plan, they are consistent with preplanned dispositions rather than opportunistic insider sales, reducing concerns about contemporaneous material information. The filing documents post-sale beneficial ownership of 79,673 shares.
TL;DR: Disclosure is clear and signed by attorney-in-fact; sale timing aligns with an existing 10b5-1 plan.
The Form 4 identifies the reporting person as President and CEO and a director, and the form is signed by an attorney-in-fact on 08/12/2025. The disclosure includes weighted average prices and explicit ranges for the multiple transactions comprising each reported sale, and it affirms the sales were effected under a 10b5-1 plan adopted on 09/04/2024. From a governance perspective, use of a 10b5-1 plan and provision of price ranges and a commitment to provide detailed transaction data on request supports transparency. The disclosure does not include any new plan adoption or other contemporaneous corporate developments.